Literature DB >> 12781911

Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections.

Tobias Böttcher1, Matthias von Mering, Sandra Ebert, Uta Meyding-Lamadé, Ulrich Kuhnt, Joachim Gerber, Roland Nau.   

Abstract

Toll-like receptors (TLR) play a key role in the recognition of microbial components. We investigated the differential regulation of TLR mRNA expression in bacterial and viral mouse models of central nervous system infection. Streptococcus pneumoniae meningitis led to an enhanced expression of TLR2, TLR4 and TLR9 mRNA. In Escherichia coli meningitis, TLR2, TLR4 and TLR7 mRNA expression was increased and Herpes simplex encephalitis caused a rise of TLR4 mRNA. In organotypic hippocampal cultures treatment with S. pneumoniae R6 led to increased expression of TLR2 and TLR3 mRNA. Our data provide evidence that regulation of TLR mRNA is not fully specific for the molecular patterns of the infectious pathogen. The TLR mRNA regulation observed probably represents a combination of specific response to the causative pathogen and non-specific activation of the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781911     DOI: 10.1016/s0304-3940(03)00404-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

1.  The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA.

Authors:  Monique Lafon; Françoise Megret; Mireille Lafage; Christophe Prehaud
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2).

Authors:  Quan M Nhu; Natalia Cuesta; Stefanie N Vogel
Journal:  J Endotoxin Res       Date:  2006

3.  Expression of Toll-like receptors and their association with cytokine responses in peripheral blood mononuclear cells of children with acute rotavirus diarrhoea.

Authors:  J Xu; Y Yang; J Sun; Y Ding; L Su; C Shao; B Jiang
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

4.  Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.

Authors:  Bibhuti B Mishra; Pramod K Mishra; Judy M Teale
Journal:  J Neuroimmunol       Date:  2006-09-29       Impact factor: 3.478

5.  Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon.

Authors:  Christophe Préhaud; Françoise Mégret; Mireille Lafage; Monique Lafon
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Myeloid-Related Protein 8/14 Participates in the Progression of Experimental Pneumococcal Meningitis by Augmentation of Inflammation.

Authors:  Danping Huang; Min Liu; Yang Zhou; Bingxin Zhao; Xuqin Chen
Journal:  J Mol Neurosci       Date:  2019-05-02       Impact factor: 3.444

7.  Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury.

Authors:  Galina Dvoriantchikova; David J Barakat; Eleut Hernandez; Valery I Shestopalov; Dmitry Ivanov
Journal:  Mol Vis       Date:  2010-09-30       Impact factor: 2.367

8.  Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration.

Authors:  Shahid Salaria; Haleh Badkoobehi; Edward Rockenstein; Leslie Crews; Gursharan Chana; Eliezer Masliah; Ian P Everall
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

Review 9.  Toll-like receptors in central nervous system glial inflammation and homeostasis.

Authors:  Tammy Kielian
Journal:  J Neurosci Res       Date:  2006-04       Impact factor: 4.164

10.  Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion.

Authors:  Fang Hua; Jing Ma; Tuanzhu Ha; Yeling Xia; Jim Kelley; David L Williams; Race L Kao; I William Browder; John B Schweitzer; John H Kalbfleisch; Chuanfu Li
Journal:  J Neuroimmunol       Date:  2007-09-19       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.